Stockreport

Cassava's Alzheimer's Therapy: A Confidence Bet [Seeking Alpha]

Cassava Sciences, Inc.  (SAVA) 
Last cassava sciences, inc. earnings: 8/12 08:30 am Check Earnings Report
PDF The research behind Cassava Sciences' Alzheimer's drug candidate, simufilam, and the idea of targeting a brain protein called filamin, is based on a series of papers fr [Read more]